RhumbLine Advisers’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.57M | Buy |
149,255
+4,936
| +3% | +$118K | ﹤0.01% | 1590 |
|
|
2025
Q1 | $3.59M | Sell |
144,319
-9,754
| -6% | -$242K | ﹤0.01% | 1521 |
|
|
2024
Q4 | $2.9M | Sell |
154,073
-7,195
| -4% | -$136K | ﹤0.01% | 1699 |
|
|
2024
Q3 | $2.43M | Buy |
161,268
+1,801
| +1% | +$27.1K | ﹤0.01% | 1805 |
|
|
2024
Q2 | $4.56M | Buy |
159,467
+9,869
| +7% | +$282K | ﹤0.01% | 1447 |
|
|
2024
Q1 | $4.37M | Buy |
149,598
+693
| +0.5% | +$20.2K | ﹤0.01% | 1483 |
|
|
2023
Q4 | $5.02M | Buy |
148,905
+7,782
| +6% | +$263K | 0.01% | 1406 |
|
|
2023
Q3 | $4.33M | Buy |
141,123
+1,074
| +0.8% | +$33K | 0.01% | 1446 |
|
|
2023
Q2 | $5.61M | Buy |
140,049
+2,930
| +2% | +$117K | 0.01% | 1308 |
|
|
2023
Q1 | $5.6M | Buy |
137,119
+6,576
| +5% | +$268K | 0.01% | 1250 |
|
|
2022
Q4 | $5.04M | Sell |
130,543
-379
| -0.3% | -$14.6K | 0.01% | 1269 |
|
|
2022
Q3 | $6.96M | Buy |
130,922
+5,287
| +4% | +$281K | 0.01% | 1074 |
|
|
2022
Q2 | $7.33M | Buy |
125,635
+8,623
| +7% | +$503K | 0.01% | 1063 |
|
|
2022
Q1 | $8.93M | Buy |
117,012
+6,585
| +6% | +$503K | 0.01% | 1000 |
|
|
2021
Q4 | $6.64M | Buy |
110,427
+1,130
| +1% | +$68K | 0.01% | 1205 |
|
|
2021
Q3 | $6.12M | Sell |
109,297
-15,251
| -12% | -$854K | 0.01% | 1235 |
|
|
2021
Q2 | $7.56M | Sell |
124,548
-1,447
| -1% | -$87.8K | 0.01% | 1179 |
|
|
2021
Q1 | $8.83M | Buy |
125,995
+324
| +0.3% | +$22.7K | 0.01% | 1070 |
|
|
2020
Q4 | $7.52M | Buy |
125,671
+6,561
| +6% | +$393K | 0.01% | 1109 |
|
|
2020
Q3 | $7.16M | Sell |
119,110
-16,424
| -12% | -$987K | 0.01% | 946 |
|
|
2020
Q2 | $7.11M | Sell |
135,534
-5,525
| -4% | -$290K | 0.01% | 969 |
|
|
2020
Q1 | $4.73M | Buy |
141,059
+859
| +0.6% | +$28.8K | 0.01% | 1057 |
|
|
2019
Q4 | $6.35M | Buy |
140,200
+12,684
| +10% | +$575K | 0.01% | 1118 |
|
|
2019
Q3 | $4.86M | Buy |
127,516
+69,364
| +119% | +$2.64M | 0.01% | 1202 |
|
|
2019
Q2 | $2.53M | Buy |
58,152
+3,627
| +7% | +$158K | ﹤0.01% | 1594 |
|
|
2019
Q1 | $2.08M | Sell |
54,525
-124
| -0.2% | -$4.72K | ﹤0.01% | 1684 |
|
|
2018
Q4 | $2.35M | Buy |
54,649
+17,258
| +46% | +$742K | 0.01% | 1538 |
|
|
2018
Q3 | $1.84M | Sell |
37,391
-2,506
| -6% | -$123K | ﹤0.01% | 1704 |
|
|
2018
Q2 | $1.28M | Buy |
39,897
+1,335
| +3% | +$42.8K | ﹤0.01% | 1905 |
|
|
2018
Q1 | $1.2M | Sell |
38,562
-1,030
| -3% | -$32.1K | ﹤0.01% | 1857 |
|
|
2017
Q4 | $1.81M | Sell |
39,592
-10,587
| -21% | -$483K | ﹤0.01% | 1683 |
|
|
2017
Q3 | $1.88M | Buy |
50,179
+976
| +2% | +$36.6K | ﹤0.01% | 1650 |
|
|
2017
Q2 | $2.35M | Buy |
49,203
+1,672
| +4% | +$79.8K | 0.01% | 1479 |
|
|
2017
Q1 | $2.17M | Buy |
47,531
+1,771
| +4% | +$80.7K | 0.01% | 1502 |
|
|
2016
Q4 | $1.48M | Buy |
45,760
+1,992
| +5% | +$64.3K | ﹤0.01% | 1630 |
|
|
2016
Q3 | $1.5M | Sell |
43,768
-948
| -2% | -$32.4K | ﹤0.01% | 1589 |
|
|
2016
Q2 | $1.51M | Buy |
44,716
+1,030
| +2% | +$34.7K | ﹤0.01% | 1548 |
|
|
2016
Q1 | $2.31M | Buy |
43,686
+1,215
| +3% | +$64.4K | 0.01% | 1269 |
|
|
2015
Q4 | $3.26M | Buy |
42,471
+3,160
| +8% | +$243K | 0.01% | 1061 |
|
|
2015
Q3 | $1.62M | Buy |
39,311
+833
| +2% | +$34.2K | 0.01% | 1459 |
|
|
2015
Q2 | $2.72M | Sell |
38,478
-1,305
| -3% | -$92.3K | 0.01% | 1211 |
|
|
2015
Q1 | $3.54M | Buy |
39,783
+6,340
| +19% | +$563K | 0.01% | 1044 |
|
|
2014
Q4 | $2.97M | Sell |
33,443
-1,565
| -4% | -$139K | 0.01% | 1101 |
|
|
2014
Q3 | $3.39M | Buy |
35,008
+140
| +0.4% | +$13.6K | 0.01% | 977 |
|
|
2014
Q2 | $3.2M | Buy |
34,868
+4,049
| +13% | +$372K | 0.01% | 1062 |
|
|
2014
Q1 | $2.16M | Sell |
30,819
-1,610
| -5% | -$113K | 0.01% | 1294 |
|
|
2013
Q4 | $1.86M | Buy |
32,429
+3,190
| +11% | +$183K | 0.01% | 1414 |
|
|
2013
Q3 | $1.41M | Buy |
29,239
+459
| +2% | +$22.1K | ﹤0.01% | 1550 |
|
|
2013
Q2 | $835K | Buy |
+28,780
| New | +$835K | ﹤0.01% | 1888 |
|